Focus: Novanta is a public medical device and biotechnology company specializing in surgical cameras and pumps across gastroenterology, neurology, ophthalmology, and respiratory markets. With ~1,000–5,000 employees and $882M in FY2025 revenue, it operates as a scaled hardware-focused medtech player.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Hot — 514 jobs added in 30d
Net +473 (514 new, 41 removed). Aggressive expansion phase.
Novanta is a stable, profitable hardware-focused medtech employer ideal for manufacturing and engineering professionals, but not for pharma scientists or clinical-stage drug developers.
Help build intelligence for Novanta
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Novanta's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Showing 6 of 10 news items
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub